Close
Open Nav

Monday, October 16, 2017 | 1:00pm - 6:30pm

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties. 

Register for the BIO SPARK Showcase

2017 BIO SPARK Showcase Presentation Schedule

Time

Spark Affiliate and Program

1:00 PM - 1:10 PM
Welcome from SPARK Translational Research Program, Stanford Medicine
  • Daria Mochly-Rosen, PhD, Director
  • Kevin Grimes, MD, Co-Director
 
1:10 PM - 1:30 PM
Stanford University- Tranquis Therapeutics
Neuroinflammation (Title not confirmed)
Ed Engleman
 
1:30 PM - 1:50 PM
National Taiwan University
Development of Potential Therapeutic Agents for Irritable Bowel Syndrome
Ling-Wei Hsin
 
1:50 PM - 2:10 PM
Kyoto University
Antivirus drug FIT-039
Dr. Masahiko Ajiro
 
2:10 PM - 2:30 PM
Stanford University
Novel SM for Alzheimer's Disease
Mehrdad Shamloo

 

 
2:30 PM - 2:40 PM
Break
 
2:40 PM - 3:00 PM
TMU SPARK
Development of Antibody Drug AP001 Against a Novel Tumor Marker Protein AP for Human Cancer Treatment
YuChing Le
 
3:00 PM - 3:20 PM
Kyoto University
Pain killer without adverse effects
Dr. Masatoshi Hagiwara
 
3:20 PM - 3:40 PM
Stanford University
Point-of-care diagnostic to measure hyperammonemia in blood
Matthew W. Kanan
 
3:40 PM - 4:00 PM
SPARK Indiana- Theratome, Inc
Injectable Biologic for Brain Ischemia
Michael Coleman
 
4:00 PM - 4:10 PM
Break
 
4:10 PM - 4:30 PM
Kyoto University
Neurogenesis inducer ALGERNON
Dr. Akiko Kobayashi
 
4:30 PM - 4:50 PM
Stanford University- Hyalos Therapeutics
Autoimmune diseases (Title not confirmed)
Marc Unger
 
4:50 PM - 5:10 PM
Kyoto University
Apoptosis inducer of cancer cells
Dr. Masaharu Toyomoto
 
5:10 PM - 5:30 PM
National Taiwan University
Novel NMDA Modulator: RS-D7
Y. Jane Tseng
 
5:30 PM - 6:30 PM
Reception
 
 
(error) (success)
(error) (success)
(error) (success)
(error) (success)
(error) (success)
(error) (success)
(error) (success)
(error) (success)
(error) (success)